Hassan Saad Abdelgaied

Dr. Hassan Saad Abdelgaied

Surgery, Zagazig University, Zagazig, Egypt

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2024 in BMC Immunology
Verified
Journal Article
Open access
PDF file
HAHassan Saad Abdelgaied
Hassan Saad Abdelgaied
ABAzza Baz
Azza Baz
MRMohamed Riad
Mohamed Riad
MEMohamed E. Eraky
Mohamed E. Eraky
AEAhmed El-Taher
Ahmed El-Taher
LILotfy A. Ibrahim
Lotfy A. Ibrahim
Background: Intra-ductal cancer (IDC) is the most common type of breast cancer, with intra-lobular cancer (ILC) coming in second. Surgery is the primary treatment for early stage breast cancer. There are now irrefutable data demonstrating that the immune context of breast tumors can influence growth and metastasis. Adjuvant chemotherapy may be administered in patients who are at a high risk of recurrence. Our goal was to identify the processes underlying both types of early local recurrences. Methods: This was a case-control observational study. Within 2 years of receiving adjuvant taxan and anthracycline-based chemotherapy, as well as modified radical mastectomy (MRM), early stage IDC and ILC recurred. Vimentin, α-smooth muscle actin (SMA), platelet-derived growth factor (PDGF), matrix metalloproteinase (MMP1), and clustered differentiation (CD95) were investigated. Results: Of the samples in the ductal type group, 25 showed local recurrence, and 25 did not. Six individuals in the lobular-type group did not experience recurrence, whereas seven did. Vimentin (p = 0.000 and 0.021), PDGF (p = 0.000 and 0.002), and CD95 (p = 0.000 and 0.045) expressions were significantly different in ductal and lobular carcinoma types, respectively. Measurement of ductal type was the sole significant difference found in MMP1 (p = 0.000) and α-SMA (p = 0.000). α-SMA and CD95 were two variables that helped the recurrence mechanism in the ductal type according to the pathway analysis. In contrast, the CD95 route is a recurrent mechanism for the lobular form. Conclusions: While the immune system plays a larger role in ILC, the tumor microenvironment and immune system both influence the recurrence of IDC. According to this study, improving the immune system may be a viable cancer treatment option.

11 August 2023 in BMC Surgery
Verified
Journal Article
Open access
PDF file
HAHassan Saad Abdelgaied
Hassan Saad Abdelgaied
RERasha S Elsayed
Rasha S Elsayed
MRMohamed Riad
Mohamed Riad
AEAhmed K. El-Taher
Ahmed K. El-Taher
MEMohamed E Eraky
Mohamed E Eraky
AAAshraf Abdelmonem
Ashraf Abdelmonem
Introduction: The spleen is a responsible significant part of the immune system; after Splenectomy following trauma, the immune system changes; splenic autotransplantation can preserve the immune system after trauma and Splenectomy. Background: Patients can be protected from immune dysfunction by autotransplanting splenic tissues after splenectomy following trauma because their immune systems and spleens are changed. Patients can gain their immune function after splenic autotransplantation. Methods: Patient classification methods are into three categories, Group A, 6 cases with auto-translation; Group B, 6 cases without transplantation; Group C, seven regular people serving as the control. Aim of work: The aim of the work is not to compare outcome methods or compare types of autotransplantation; This work aims to document postoperative radiological, immunological, clinical, and hematological investigations. We concentrated on the results of investigations more than the types of operation or approach or types of autotransplantation. Results: We showed that, after comparing each group with normal individuals subjects, patients who did not undergo autotransplantation had significantly higher platelet counts, a more significant percentage of micronucleated reticulocytes, increased levels of naive B lymphocytes, changes in class-switched memory and class-unswitched memory B cells, and higher levels of PD1 on CD8 + T lymphocytes. Nevertheless, neither splenic autotransplant patients nor the average general population showed any appreciable variations in any of the parameters. Conclusions: Spleen’s activities with adequate hemocatheter activity and recovery of the immunological deficit after splenic autotransplantation.

21 September 2023 in Research Square
Verified
Preprint
Open access
PDF file
HAHassan Saad Abdelgaied
Hassan Saad Abdelgaied
MEMohamed E. Eraky
Mohamed E. Eraky
AEAhmed K El-Tahe
Ahmed K El-Tahe
MRMohamed Riad
Mohamed Riad
MFMohamed I Farid
Mohamed I Farid
KSKhaled Sharaf
Khaled Sharaf
Objective The present study aimed to examine the clinical importance of preoperative total bilirubinemia in patients with acute appendicitis and to determine whether it has any practical application for predicting severe appendicitis. Methods A retrospective analysis of appendicectomies was performed at one hospital ( 636 cases of acute appendicitis presenting to the emergency department between December 2019 and January 2023). Using multivariate analysis, we examined predictive data for complex (perforated or gangrenous) appendicitis, including demographics, sex, white blood cell count, degree of C-reactive protein (CRP) elevation, high-temperature peritoneal signs and indicators, and total bilirubin levels. Results Those with total bilirubin (> 1.1 mg/dL), high C-reactive protein (CRP) levels (> 0.5 mg/dL), positive peritoneal irritated symptoms, and temperature (> 37.3 C) had considerably higher rates of acute appendicitis. Age (> 64 years), hyperbilirubinemia, high CRP levels, and fever (odds ratios of 3.36, 1.75, 7.61, and 2.43, respectively) were identified by multivariate analysis as associated risks for complex appendicitis. This is particularly true for those under 65 years of age. Conclusions High temperature, elevated CRP level, and high total bilirubin level were good predictors of acute appendicitis, especially in patients younger than 65 years; however, total bilirubin level was a more precise indicator.

17 October 2024 in BMC Immunology
Verified
Journal Article
Open access
PDF file
HAHassan Saad Abdelgaied
Hassan Saad Abdelgaied
ABAzza Baz
Azza Baz
MRMohamed Riad
Mohamed Riad
MEMohamed E. Eraky
Mohamed E. Eraky
AEAhmed El-Taher
Ahmed El-Taher
LILotfy A. Ibrahim
Lotfy A. Ibrahim

1 April 2023 in The Egyptian Journal of Hospital Medicine
Verified
Journal Article
Open access
PDF file
HAHassan Saad Abdelgaied
Hassan Saad Abdelgaied
AEAshraf Abdelmonem Elsayed
Ashraf Abdelmonem Elsayed
MEMohamed E Eraky
Mohamed E Eraky
RERasha S Elsayed
Rasha S Elsayed
MRMohamed Riad
Mohamed Riad
Background: Chemotherapy plays a significant part in the management of breast cancer. In the current study, mastectomy with prompt breast reconstruction, the effects of neoadjuvant and adjuvant chemotherapy were investigated. Objective: The effect of neoadjuvant and adjuvant were given systemically to breast cancer patients to investigate their effect on breast reconstruction following mastectomy. Methods: Two-year postoperative follow-up at Zagazig University Surgical Department for 82 patients who received assistance systemic neoadjuvant (NAC) and (ACT) adjuvant chemotherapy for breast cancer between January 2021 and December 2022, together with mastectomy and rapid reconstructive surgery of the breast. Results: During the trial, 82 patients received fast breast remodeling after mastectomy. 34 patients did not receive any systemic therapy, whereas 28 patients had preoperative chemotherapy and 20 patients received postoperative chemotherapy. Conclusion: There were no differences in unscheduled reoperation, donor-site complications, or expander loss across the groups although the adjuvant chemotherapy group had a substantial number of wounds that were infected.

1 January 2024
Verified
Journal Article
Open access
PDF file
HAHassan Saad Abdelgaied
Hassan Saad Abdelgaied
ABAzza Baz
Azza Baz
MRMohamed Riad
Mohamed Riad
MEMohamed E Eraky
Mohamed E Eraky
MFMohamed I Farid
Mohamed I Farid
KSKhaled Sharaf
Khaled Sharaf
An elevated risk of mortality, secondary sarcopenia, multiorgan dysfunction, sepsis, and severe oxidative stress are all brought on by major burn injuries. They also set off a systemic inflammatory response and a chronic hypermetabolic and hypercatabolic state. Following heat damage, poor clinical outcomes have been linked to calorie shortfalls, negative protein balance, and antioxidant micronutrient insufficiency. In this situation, early enteral feeding at the onset of resuscitation, together with tailored nutrition therapy, is recommended. Various pharmacological and dietary therapies targeting immunological and metabolic response modulation have been studied during the past 40 years. In this patient population, these tactics have demonstrated the ability to reduce acute malnutrition, control the immunoinflammatory response, and enhance pertinent clinical outcomes. Summarising the most recent research on nutrition therapy and metabolic response in critically ill burn patients is the aim of this updated review. Keywords Burn wounds; Emergency medical care; Intense metabolism; Acrometalization; Tiny nutrition; Phospholipid